These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9854478)

  • 21. Expression of the apoptosis-related genes Bcl-2 and p53 in clinical samples from endometrial carcinoma patients.
    González-Rodilla I; Verna V; Muñoz AB; Estévez J; Boix M; Schneider J
    Anticancer Res; 2011 Dec; 31(12):4191-3. PubMed ID: 22199279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
    Wang X; Huang Z; Di W; Lin Q
    Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck.
    Staibano S; Lo Muzio L; Pannone G; Scalvenzi M; Salvatore G; Errico ME; Fanali S; De Rosa G; Piattelli A
    Anticancer Res; 2001; 21(6A):3757-64. PubMed ID: 11911244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
    Bell JG; Minnick A; Reid GC; Judis J; Brownell M
    Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
    Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role of thymidine phosphorylase and P53 tissue protein expression in biology of endometrial cancer.
    Mazurek A; Kuć P; Mazurek-Wadołkowska E; Laudański T
    Neoplasma; 2008; 55(3):261-5. PubMed ID: 18348659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorescence in situ hybridization and immunohistochemical analysis of p53 expression in endometrial cancer: prognostic value and relation to ploidy.
    Graesslin O; Chantot-Bastaraud S; Lorenzato M; Birembaut P; Quéreux C; Daraï E
    Ann Surg Oncol; 2008 Feb; 15(2):484-92. PubMed ID: 18071824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase activity and Bcl-2 expression in non-small cell lung cancer.
    Ohmura Y; Aoe M; Andou A; Shimizu N
    Clin Cancer Res; 2000 Aug; 6(8):2980-7. PubMed ID: 10955774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
    Giordano G; Gnetti L; Merisio C; Melpignano M
    Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of vascular endothelial growth factor and thymidine phosphorylase in endometrial cancer.
    Fujiwaki R; Hata K; Iida K; Maede Y; Watanabe Y; Koike M; Miyazaki K
    Acta Obstet Gynecol Scand; 1999 Sep; 78(8):728-34. PubMed ID: 10468067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma.
    Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
    Br J Cancer; 1999 Jun; 80(7):1075-9. PubMed ID: 10362119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ; Deavers MT; Malpica A; Foster H; McCluggage WG
    Am J Surg Pathol; 2005 Aug; 29(8):1034-41. PubMed ID: 16006797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus.
    Jiko K; Sasano H; Ito K; Ozawa N; Sato S; Yajima A
    Anticancer Res; 1993; 13(2):305-10. PubMed ID: 8517643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between p53 expression, stage and histological features in endometrial cancer.
    Ragni N; Ferrero S; Prefumo F; Muschiato B; Gorlero F; Gualco M; Fulcheri E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):111-6. PubMed ID: 15894417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma.
    Vaskivuo TE; Stenbäck F; Tapanainen JS
    Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
    Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
    Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.